Salazar, Princess .

HRN: 25-63-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2024
CEFUROXIME 1.5GM (VIAL)
08/08/2024
08/15/2024
IV
400mg
Q8h
PCAP
Waiting Final Action 
08/13/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
08/14/2024
08/17/2024
PO
3 Ml
BID
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: